BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27006085)

  • 1. The Effect of rhCygb on CCl4-Induced Hepatic Fibrogenesis in Rat.
    Li Z; Wei W; Chen B; Cai G; Li X; Wang P; Tang J; Dong W
    Sci Rep; 2016 Mar; 6():23508. PubMed ID: 27006085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous hydrogen sulfide is associated with angiotensin II type 1 receptor in a rat model of carbon tetrachloride-induced hepatic fibrosis.
    Fan HN; Chen NW; Shen WL; Zhao XY; Zhang J
    Mol Med Rep; 2015 Sep; 12(3):3351-3358. PubMed ID: 26034979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebamipide retards CCl4-induced hepatic fibrosis in rats: Possible role for PGE2.
    Zakaria S; El-Sisi A
    J Immunotoxicol; 2016 Jul; 13(4):453-62. PubMed ID: 26849241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats.
    Wei YH; Jun L; Qiang CJ
    Dig Dis Sci; 2004 Oct; 49(10):1589-94. PubMed ID: 15573910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoprotective Effects of Grape Seed Procyanidin B2 in Rats With Carbon Tetrachloride-induced Hepatic Fibrosis.
    Wang Z; Zhang Z; Du N; Wang K; Li L
    Altern Ther Health Med; 2015; 21 Suppl 2():12-21. PubMed ID: 26308756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatoprotection by freshwater clam extract against CCl4-induced hepatic damage in rats.
    Hsu CL; Hsu CC; Yen GC
    Am J Chin Med; 2010; 38(5):881-94. PubMed ID: 20821820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protective effect of Tanreqing injection on acute hepatic injury induced by CCl4 in rats].
    Lei Y; Zhou AM; Guo T; Tan Y; Tao YY; Liu CH
    Zhongguo Zhong Yao Za Zhi; 2013 Apr; 38(8):1226-30. PubMed ID: 23944040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-treatment of melatonin with CCl
    Mortezaee K; Majidpoor J; Daneshi E; Abouzaripour M; Abdi M
    J Cell Biochem; 2018 Feb; 119(2):1716-1725. PubMed ID: 28782839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antioxidant and antifibrogenic effects of the glycosaminoglycans hyaluronic acid and chondroitin-4-sulphate in a subchronic rat model of carbon tetrachloride-induced liver fibrogenesis.
    Campo GM; Avenoso A; Campo S; D'Ascola A; Ferlazzo AM; Calatroni A
    Chem Biol Interact; 2004 Jul; 148(3):125-38. PubMed ID: 15276869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of recombinant human cytoglobin against chronic alcohol-induced liver disease in vivo and in vitro.
    Wen J; Wu Y; Wei W; Li Z; Wang P; Zhu S; Dong W
    Sci Rep; 2017 Jan; 7():41647. PubMed ID: 28128325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibitory effect of acupuncture on hepatic extracellular matrix production in carbon tetrachloride-induced liver fibrosis rats].
    Zhang F; Ma J; Lu Y; Ni GX; Ni CY; Zhang XJ; Wang AY; Zheng SZ
    Zhen Ci Yan Jiu; 2012 Feb; 37(1):8-14. PubMed ID: 22574562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats.
    Tsai JH; Liu JY; Wu TT; Ho PC; Huang CY; Shyu JC; Hsieh YS; Tsai CC; Liu YC
    J Viral Hepat; 2008 Jul; 15(7):508-14. PubMed ID: 18397225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-fibrotic effects of puerarin on CCl4-induced hepatic fibrosis in rats possibly through the regulation of PPAR-γ expression and inhibition of PI3K/Akt pathway.
    Guo C; Xu L; He Q; Liang T; Duan X; Li R
    Food Chem Toxicol; 2013 Jun; 56():436-42. PubMed ID: 23500774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of leflunomide on hepatic fibrosis induced by CCl4 in rats.
    Yao HW; Li J; Chen JQ; Xu SY
    Acta Pharmacol Sin; 2004 Jul; 25(7):915-20. PubMed ID: 15210065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the effects of blueberry treatment on histone acetylation modification of CCl
    Zhan W; Liao X; Tian T; Yu L; Liu X; Li B; Liu J; Han B; Xie RJ; Ji QH; Yang Q
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28218781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potential of morin against liver fibrosis in rats: modulation of oxidative stress, cytokine production and nuclear factor kappa B.
    Heeba GH; Mahmoud ME
    Environ Toxicol Pharmacol; 2014 Mar; 37(2):662-71. PubMed ID: 24583409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection by and anti-oxidant mechanism of berberine against rat liver fibrosis induced by multiple hepatotoxic factors.
    Zhang BJ; Xu D; Guo Y; Ping J; Chen LB; Wang H
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):303-9. PubMed ID: 17973934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of shuganjianpifang on the expression of BCL-2 and BAX in rats livers with hepatic fibrosis].
    Jiang H; Gao JR; Chen JF; Ji WB
    Zhong Yao Cai; 2013 May; 36(5):776-80. PubMed ID: 24218972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.
    Ryeom HK; Kim SH; Kim JY; Kim HJ; Lee JM; Chang YM; Kim YS; Kang DS
    Korean J Radiol; 2004; 5(4):231-9. PubMed ID: 15637473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of gallic acid on CCl4-mediated liver fibrosis in mice.
    Wang J; Tang L; White J; Fang J
    Cell Biochem Biophys; 2014 May; 69(1):21-6. PubMed ID: 24096707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.